TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/9/21 16:19 | 7/8/21 | NEXI | Neximmune, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Trainer John | MD | O | CFO | M.d | 18 | 5.17 | 0 | 3 | 6 | 62 | D | ||||||||||||||
6/9/21 16:06 | 6/8/21 | NEXI | Neximmune, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Trainer John | MD | O | CFO | M.d | 18 | 5.17 | 0 | 3 | 6 | 58 | D | ||||||||||||||
5/19/21 16:16 | 4/8/21 | NEXI | Neximmune, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Trainer John | MD | O | CFO | M.dm | 35 | 5.17 | 0 | 7 | 14 | 55 | D | ||||||||||||||
3/12/21 14:00 | 3/10/21 | NEXI | Neximmune, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Trainer John | MD | O | CFO | M.d | 18 | 5.17 | 0 | 3 | 8 | 48 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |